Organometallic Ru(<scp>ii</scp>), Rh(<scp>iii</scp>) and Re(<scp>i</scp>) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity-Reference-Cited by-同舟云学术

Organometallic Ru(ii), Rh(iii) and Re(i) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity

Published:2024 Issue:11 Volume:53 Page:4984-5000
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Pivarcsik Tamás¹²^ORCID,Kiss Márton A.²^ORCID,Rapuš Uroš³^ORCID,Kljun Jakob³^ORCID,Spengler Gabriella¹⁴^ORCID,Frank Éva²^ORCID,Turel Iztok³^ORCID,Enyedy Éva A.¹²^ORCID

Affiliation:

1. MTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8., H–6720 Szeged, Hungary

2. Department of Molecular and Analytical Chemistry, University of Szeged, Dóm tér 7-8., H–6720 Szeged, Hungary

3. Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI–1000 Ljubljana, Slovenia

4. Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary

Abstract

Synthesis, characterization, solution speciation, binding affinity towards biomolecules and anticancer activity of organometallic Ru(ii), Rh(iii) and Re(i) complexes of (N,N) donor 5α-dihydrotestosterone-based hybrid ligands.

Funder

Innovációs és Technológiai Minisztérium

Univerza v Ljubljani

Javna Agencija za Raziskovalno Dejavnost RS

Magyar Tudományos Akadémia

European Cooperation in Science and Technology

National Research, Development and Innovation Office

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/DT/D3DT04138G

Reference74 articles.

1. Metal-based drugs that break the rules

2. Organometallic Compounds: An Opportunity for Chemical Biology?

3. Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents

4. Organometallic Anticancer Compounds

5. Challenges and Opportunities in the Development of Organometallic Anticancer Drugs